Company / Cost of Revenue
Nuvation Bio Inc. Cost of Revenue History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$7.1M
FY2024
5-year range
$0 / $7.1M
FY2023-FY2024
Trend
-
vs FY2023
Sector context
#72 of 85
Health Care
What the data says
Nuvation Bio Inc.'s cost of revenue of $7M is lower than 85% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
$7M in FY2024.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 85This company $7.1M Sector average $2.0B
▼
-99.6% below sector average
Key checks
Key Insights
- Ranks #72 out of 85 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $7.1M | - |
| FY2023 | $0 | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026